Tartrate‐resistant acid phosphatase (TRAP) staining further revealed that EGFR is dispensable for osteoclastogenesis in H2‐c‐fosLTR‐derived bone tumors (Fig EV2B). Here, EGFR is linked to bone neoplasm.